We've found
					11,964 Cardiology				
					clinical trials				
				
			
		
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases Clinical Trial
	A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases Clinical Trial
	A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases Clinical Trial
	A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases Clinical Trial
	A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases Clinical Trial
	A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases Clinical Trial
	A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases Clinical Trial
	A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases Clinical Trial
	A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Chronic Heart Failure (CHF) Clinical Trial
	Efficacy and Safety of LCZ696 Compared to Valsartan on Cognitive Function in Patients With Chronic Heart Failure and Preserved Ejection Fraction
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Chronic Heart Failure (CHF) Clinical Trial
	Efficacy and Safety of LCZ696 Compared to Valsartan on Cognitive Function in Patients With Chronic Heart Failure and Preserved Ejection Fraction
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology Clinical Trial
	Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
		Status: Enrolling
  
							
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology Clinical Trial
	Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
		Status: Enrolling
  
							
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology Clinical Trial
	Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
		Status: Enrolling
  
							
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology Clinical Trial
	Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
		Status: Enrolling
  
							
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology Clinical Trial
	Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
		Status: Enrolling
  
							
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology Clinical Trial
	Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
		Status: Enrolling
  
							
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology Clinical Trial
	Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
		Status: Enrolling
  
							
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology Clinical Trial
	Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
		Status: Enrolling
  
							
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology Clinical Trial
	Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
		Status: Enrolling
  
							
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology Clinical Trial
	Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
		Status: Enrolling
  
							
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Oncology Clinical Trial
	Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
		Status: Enrolling
  
							
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Thrombosis Clinical Trial
	Pharmacokinetic, Pharmacodynamic, Safety, and Efficacy Study of Rivaroxaban for Thromboprophylaxis in Pediatric Participants 2 to 8 Years of Age After the Fontan Procedure
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Thrombosis Clinical Trial
	Pharmacokinetic, Pharmacodynamic, Safety, and Efficacy Study of Rivaroxaban for Thromboprophylaxis in Pediatric Participants 2 to 8 Years of Age After the Fontan Procedure
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases Clinical Trial
	Evaluation of the GORE® TAG® Thoracic Branch Endoprosthesis (TBE Device) in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta (Zone 0/1)
		Status: Enrolling
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	Evaluation of the GORE® TAG® Thoracic Branch Endoprosthesis (TBE Device) in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta (Zone 0/1)
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Hematology Clinical Trial
	A Randomized Multicenter Study for Isolated Skin Vasculitis
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Cardiology / Vascular Diseases, Hematology Clinical Trial
	A Randomized Multicenter Study for Isolated Skin Vasculitis
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Myocardial Infarction Clinical Trial
	Women's Heart Attack Research Program: Stress Ancillary Study
		Status: Enrolling
  
							
  	
	Myocardial Infarction Clinical Trial
	Women's Heart Attack Research Program: Stress Ancillary Study
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Thrombosis Clinical Trial
	A Study of the Safety and Pharmacokinetics of Apixaban Versus Vitamin K Antagonist (VKA) or Low Molecular Weight Heparin (LMWH) in Pediatric Subjects With Congenital or Acquired Heart Disease Requiring Anticoagulation
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Thrombosis Clinical Trial
	A Study of the Safety and Pharmacokinetics of Apixaban Versus Vitamin K Antagonist (VKA) or Low Molecular Weight Heparin (LMWH) in Pediatric Subjects With Congenital or Acquired Heart Disease Requiring Anticoagulation
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Functional Single Ventricle Heart Disease Clinical Trial
	A Extension Study of Udenafil in Adolescents
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Functional Single Ventricle Heart Disease Clinical Trial
	A Extension Study of Udenafil in Adolescents
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Functional Single Ventricle Heart Disease Clinical Trial
	A Extension Study of Udenafil in Adolescents
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Functional Single Ventricle Heart Disease Clinical Trial
	A Extension Study of Udenafil in Adolescents
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Hypoplastic Left Heart Syndrome (HLHS) Clinical Trial
	National Collaborative to Improve Care of Children With Complex Congenital Heart Disease
		Status: Enrolling,
							Phase
  
							
  	
	Hypoplastic Left Heart Syndrome (HLHS) Clinical Trial
	National Collaborative to Improve Care of Children With Complex Congenital Heart Disease
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 4/9/2018	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Hypoplastic Left Heart Syndrome (HLHS) Clinical Trial
	National Collaborative to Improve Care of Children With Complex Congenital Heart Disease
		Status: Enrolling,
							Phase
  
							
  	
	Hypoplastic Left Heart Syndrome (HLHS) Clinical Trial
	National Collaborative to Improve Care of Children With Complex Congenital Heart Disease
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 4/9/2018	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Hypoplastic Left Heart Syndrome (HLHS) Clinical Trial
	National Collaborative to Improve Care of Children With Complex Congenital Heart Disease
		Status: Enrolling,
							Phase
  
							
  	
	Hypoplastic Left Heart Syndrome (HLHS) Clinical Trial
	National Collaborative to Improve Care of Children With Complex Congenital Heart Disease
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 4/9/2018	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Orthopedics / Podiatry Clinical Trial
	Open-Label Study of Perhexiline in Patients With Hypertrophic Cardiomyopathy and Moderate to Severe Heart Failure
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Cardiology / Vascular Diseases, Orthopedics / Podiatry Clinical Trial
	Open-Label Study of Perhexiline in Patients With Hypertrophic Cardiomyopathy and Moderate to Severe Heart Failure
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 2/16/2017	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Orthopedics / Podiatry Clinical Trial
	Open-Label Study of Perhexiline in Patients With Hypertrophic Cardiomyopathy and Moderate to Severe Heart Failure
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Cardiology / Vascular Diseases, Orthopedics / Podiatry Clinical Trial
	Open-Label Study of Perhexiline in Patients With Hypertrophic Cardiomyopathy and Moderate to Severe Heart Failure
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 2/16/2017	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Orthopedics / Podiatry Clinical Trial
	Open-Label Study of Perhexiline in Patients With Hypertrophic Cardiomyopathy and Moderate to Severe Heart Failure
		Status: Enrolling,
							Phase
													 II
  
							
  	
	Cardiology / Vascular Diseases, Orthopedics / Podiatry Clinical Trial
	Open-Label Study of Perhexiline in Patients With Hypertrophic Cardiomyopathy and Moderate to Severe Heart Failure
		Status: Enrolling,
							Phase
													 II			
				
		
	
	
			Updated: 2/16/2017	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Carotid Artery Stenosis Clinical Trial
	Evaluation of the Roadsaver Stent Used in Conjunction With the Nanoparasol Embolic Protection System for Carotid Artery Stenosis
		Status: Enrolling
  
							
  	
	Carotid Artery Stenosis Clinical Trial
	Evaluation of the Roadsaver Stent Used in Conjunction With the Nanoparasol Embolic Protection System for Carotid Artery Stenosis
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Carotid Artery Stenosis Clinical Trial
	Evaluation of the Roadsaver Stent Used in Conjunction With the Nanoparasol Embolic Protection System for Carotid Artery Stenosis
		Status: Enrolling
  
							
  	
	Carotid Artery Stenosis Clinical Trial
	Evaluation of the Roadsaver Stent Used in Conjunction With the Nanoparasol Embolic Protection System for Carotid Artery Stenosis
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	CardiAMP™ Heart Failure Trial
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Heart Failure Clinical Trial
	CardiAMP™ Heart Failure Trial
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	CardiAMP™ Heart Failure Trial
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Heart Failure Clinical Trial
	CardiAMP™ Heart Failure Trial
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Bradycardia Clinical Trial
	Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
  
							
  	
	Bradycardia Clinical Trial
	Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Bradycardia Clinical Trial
	Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
  
							
  	
	Bradycardia Clinical Trial
	Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Bradycardia Clinical Trial
	Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
  
							
  	
	Bradycardia Clinical Trial
	Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Bradycardia Clinical Trial
	Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
  
							
  	
	Bradycardia Clinical Trial
	Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Bradycardia Clinical Trial
	Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
  
							
  	
	Bradycardia Clinical Trial
	Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Bradycardia Clinical Trial
	Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
  
							
  	
	Bradycardia Clinical Trial
	Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Bradycardia Clinical Trial
	Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
  
							
  	
	Bradycardia Clinical Trial
	Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Bradycardia Clinical Trial
	Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
  
							
  	
	Bradycardia Clinical Trial
	Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Bradycardia Clinical Trial
	Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
  
							
  	
	Bradycardia Clinical Trial
	Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Bradycardia Clinical Trial
	Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
  
							
  	
	Bradycardia Clinical Trial
	Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Bradycardia Clinical Trial
	Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
  
							
  	
	Bradycardia Clinical Trial
	Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Neurology Clinical Trial
	EDS in Ataxia Telangiectasia Patients
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases, Neurology Clinical Trial
	EDS in Ataxia Telangiectasia Patients
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Hematology Clinical Trial
	Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases, Hematology Clinical Trial
	Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Hematology Clinical Trial
	Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases, Hematology Clinical Trial
	Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Hematology Clinical Trial
	Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases, Hematology Clinical Trial
	Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Hematology Clinical Trial
	Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases, Hematology Clinical Trial
	Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Hematology Clinical Trial
	Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases, Hematology Clinical Trial
	Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Hematology Clinical Trial
	Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases, Hematology Clinical Trial
	Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Hematology Clinical Trial
	Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases, Hematology Clinical Trial
	Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Hematology Clinical Trial
	Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases, Hematology Clinical Trial
	Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Hematology Clinical Trial
	Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases, Hematology Clinical Trial
	Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Hematology Clinical Trial
	Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases, Hematology Clinical Trial
	Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Hematology Clinical Trial
	Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases, Hematology Clinical Trial
	Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Hematology Clinical Trial
	Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases, Hematology Clinical Trial
	Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	Strategic MAnagement to Optimize Response To Cardiac Resynchronization Therapy Registry
		Status: Enrolling,
							Phase
  
							
  	
	Heart Failure Clinical Trial
	Strategic MAnagement to Optimize Response To Cardiac Resynchronization Therapy Registry
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	The Inotrope Evaluation and Research Patient Registry
		Status: Enrolling,
							Phase
  
							
  	
	Heart Failure Clinical Trial
	The Inotrope Evaluation and Research Patient Registry
		Status: Enrolling,
							Phase
													 			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Orthopedics / Podiatry Clinical Trial
	The PARTNER 3 - AVIV Trial
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases, Orthopedics / Podiatry Clinical Trial
	The PARTNER 3 - AVIV Trial
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases, Orthopedics / Podiatry Clinical Trial
	The PARTNER 3 - AVIV Trial
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases, Orthopedics / Podiatry Clinical Trial
	The PARTNER 3 - AVIV Trial
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
		Status: Enrolling
  
							
  	
	Heart Failure Clinical Trial
	Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
		Status: Enrolling
  
							
  	
	Heart Failure Clinical Trial
	Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Aortic Valve Stenosis Clinical Trial
	Prehabilitation for Patients Undergoing Transcatheter Aortic Valve Replacement
		Status: Enrolling
  
							
  	
	Aortic Valve Stenosis Clinical Trial
	Prehabilitation for Patients Undergoing Transcatheter Aortic Valve Replacement
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Aortic Valve Stenosis Clinical Trial
	Prehabilitation for Patients Undergoing Transcatheter Aortic Valve Replacement
		Status: Enrolling
  
							
  	
	Aortic Valve Stenosis Clinical Trial
	Prehabilitation for Patients Undergoing Transcatheter Aortic Valve Replacement
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Heart Failure Clinical Trial
	EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Heart Failure Clinical Trial
	EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Heart Failure Clinical Trial
	EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Heart Failure Clinical Trial
	EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Heart Failure Clinical Trial
	EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Heart Failure Clinical Trial
	EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Heart Failure Clinical Trial
	EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Heart Failure Clinical Trial
	EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Heart Failure Clinical Trial
	EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Heart Failure Clinical Trial
	EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Acute Myocardial Infarction Clinical Trial
	Prospective ARNI vs ACE Inhibitor Trial to DetermIne Superiority in Reducing Heart Failure Events After MI
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Acute Myocardial Infarction Clinical Trial
	Prospective ARNI vs ACE Inhibitor Trial to DetermIne Superiority in Reducing Heart Failure Events After MI
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Acute Myocardial Infarction Clinical Trial
	Prospective ARNI vs ACE Inhibitor Trial to DetermIne Superiority in Reducing Heart Failure Events After MI
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Acute Myocardial Infarction Clinical Trial
	Prospective ARNI vs ACE Inhibitor Trial to DetermIne Superiority in Reducing Heart Failure Events After MI
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
		Status: Enrolling
  
							
  	
	Heart Failure Clinical Trial
	Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
		Status: Enrolling
  
							
  	
	Heart Failure Clinical Trial
	Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
		Status: Enrolling
  
							
  	
	Heart Failure Clinical Trial
	Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	QP ExCELs: MultiPole Pacing (MPP) Sub-Study
		Status: Enrolling
  
							
  	
	Heart Failure Clinical Trial
	QP ExCELs: MultiPole Pacing (MPP) Sub-Study
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	QP ExCELs: MultiPole Pacing (MPP) Sub-Study
		Status: Enrolling
  
							
  	
	Heart Failure Clinical Trial
	QP ExCELs: MultiPole Pacing (MPP) Sub-Study
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	QP ExCELs: MultiPole Pacing (MPP) Sub-Study
		Status: Enrolling
  
							
  	
	Heart Failure Clinical Trial
	QP ExCELs: MultiPole Pacing (MPP) Sub-Study
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	QP ExCELs: MultiPole Pacing (MPP) Sub-Study
		Status: Enrolling
  
							
  	
	Heart Failure Clinical Trial
	QP ExCELs: MultiPole Pacing (MPP) Sub-Study
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	QP ExCELs: MultiPole Pacing (MPP) Sub-Study
		Status: Enrolling
  
							
  	
	Heart Failure Clinical Trial
	QP ExCELs: MultiPole Pacing (MPP) Sub-Study
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	QP ExCELs: MultiPole Pacing (MPP) Sub-Study
		Status: Enrolling
  
							
  	
	Heart Failure Clinical Trial
	QP ExCELs: MultiPole Pacing (MPP) Sub-Study
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	QP ExCELs: MultiPole Pacing (MPP) Sub-Study
		Status: Enrolling
  
							
  	
	Heart Failure Clinical Trial
	QP ExCELs: MultiPole Pacing (MPP) Sub-Study
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	QP ExCELs: MultiPole Pacing (MPP) Sub-Study
		Status: Enrolling
  
							
  	
	Heart Failure Clinical Trial
	QP ExCELs: MultiPole Pacing (MPP) Sub-Study
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Heart Failure Clinical Trial
	QP ExCELs: MultiPole Pacing (MPP) Sub-Study
		Status: Enrolling
  
							
  	
	Heart Failure Clinical Trial
	QP ExCELs: MultiPole Pacing (MPP) Sub-Study
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases Clinical Trial
	Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases Clinical Trial
	Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases Clinical Trial
	Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Cardiology / Vascular Diseases Clinical Trial
	Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Cardiology / Vascular Diseases Clinical Trial
	Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Pulmonary Hypertension Associated With HFpEF Clinical Trial
	Study of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) Associated With Heart Failure With Preserved Ejection Fraction (HFpEF)
		Status: Enrolling,
							Phase
													 III
  
							
  	
	Pulmonary Hypertension Associated With HFpEF Clinical Trial
	Study of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) Associated With Heart Failure With Preserved Ejection Fraction (HFpEF)
		Status: Enrolling,
							Phase
													 III			
				
		
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 Sudden Cardiac Death Clinical Trial
	Assessment of Primary Prevention Patients Receiving An ICD - Systematic Evaluation of ATP
		Status: Enrolling
  
							
  	
	Sudden Cardiac Death Clinical Trial
	Assessment of Primary Prevention Patients Receiving An ICD - Systematic Evaluation of ATP
		Status: Enrolling	
	
	
			Updated: 12/31/1969	
	  
  
  
  
			Click here to add this to my saved trials
	    
	 
  
						
				
			
We've found
					11,964 Cardiology
				
					clinical trials
				
				
				
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Chronic Heart Failure (CHF) Clinical Trial
	
Updated: 12/31/1969
  
  
  Efficacy and Safety of LCZ696 Compared to Valsartan on Cognitive Function in Patients With Chronic Heart Failure and Preserved Ejection Fraction
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Oncology Clinical Trial
	
Updated: 12/31/1969
  
  
  Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Thrombosis Clinical Trial
	
Updated: 12/31/1969
  
  
  Pharmacokinetic, Pharmacodynamic, Safety, and Efficacy Study of Rivaroxaban for Thromboprophylaxis in Pediatric Participants 2 to 8 Years of Age After the Fontan Procedure
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 12/31/1969
  
  
  Evaluation of the GORE® TAG® Thoracic Branch Endoprosthesis (TBE Device) in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta (Zone 0/1)
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Hematology Clinical Trial
	
Updated: 12/31/1969
  
  
  A Randomized Multicenter Study for Isolated Skin Vasculitis
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Myocardial Infarction Clinical Trial
	
Updated: 12/31/1969
  
  
  Women's Heart Attack Research Program: Stress Ancillary Study
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Thrombosis Clinical Trial
	
Updated: 12/31/1969
  
  
  A Study of the Safety and Pharmacokinetics of Apixaban Versus Vitamin K Antagonist (VKA) or Low Molecular Weight Heparin (LMWH) in Pediatric Subjects With Congenital or Acquired Heart Disease Requiring Anticoagulation
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Functional Single Ventricle Heart Disease Clinical Trial
	
Updated: 12/31/1969
  
  
  A Extension Study of Udenafil in Adolescents
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Functional Single Ventricle Heart Disease Clinical Trial
	
Updated: 12/31/1969
  
  
  A Extension Study of Udenafil in Adolescents
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Hypoplastic Left Heart Syndrome (HLHS) Clinical Trial
	
Updated: 4/9/2018
  
  
  National Collaborative to Improve Care of Children With Complex Congenital Heart Disease
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 4/9/2018
Click here to add this to my saved trials
	    
	 
  	
	Hypoplastic Left Heart Syndrome (HLHS) Clinical Trial
	
Updated: 4/9/2018
  
  
  National Collaborative to Improve Care of Children With Complex Congenital Heart Disease
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 4/9/2018
Click here to add this to my saved trials
	    
	 
  	
	Hypoplastic Left Heart Syndrome (HLHS) Clinical Trial
	
Updated: 4/9/2018
  
  
  National Collaborative to Improve Care of Children With Complex Congenital Heart Disease
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 4/9/2018
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Orthopedics / Podiatry Clinical Trial
	
Updated: 2/16/2017
  
  
  Open-Label Study of Perhexiline in Patients With Hypertrophic Cardiomyopathy and Moderate to Severe Heart Failure
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 2/16/2017
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Orthopedics / Podiatry Clinical Trial
	
Updated: 2/16/2017
  
  
  Open-Label Study of Perhexiline in Patients With Hypertrophic Cardiomyopathy and Moderate to Severe Heart Failure
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 2/16/2017
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Orthopedics / Podiatry Clinical Trial
	
Updated: 2/16/2017
  
  
  Open-Label Study of Perhexiline in Patients With Hypertrophic Cardiomyopathy and Moderate to Severe Heart Failure
		Status: Enrolling,
							Phase
													 II			
				
		
	Updated: 2/16/2017
Click here to add this to my saved trials
	    
	 
  	
	Carotid Artery Stenosis Clinical Trial
	
Updated: 12/31/1969
  
  
  Evaluation of the Roadsaver Stent Used in Conjunction With the Nanoparasol Embolic Protection System for Carotid Artery Stenosis
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Carotid Artery Stenosis Clinical Trial
	
Updated: 12/31/1969
  
  
  Evaluation of the Roadsaver Stent Used in Conjunction With the Nanoparasol Embolic Protection System for Carotid Artery Stenosis
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  CardiAMP™ Heart Failure Trial
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  CardiAMP™ Heart Failure Trial
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Bradycardia Clinical Trial
	
Updated: 12/31/1969
  
  
  Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Bradycardia Clinical Trial
	
Updated: 12/31/1969
  
  
  Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Bradycardia Clinical Trial
	
Updated: 12/31/1969
  
  
  Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Bradycardia Clinical Trial
	
Updated: 12/31/1969
  
  
  Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Bradycardia Clinical Trial
	
Updated: 12/31/1969
  
  
  Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Bradycardia Clinical Trial
	
Updated: 12/31/1969
  
  
  Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Bradycardia Clinical Trial
	
Updated: 12/31/1969
  
  
  Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Bradycardia Clinical Trial
	
Updated: 12/31/1969
  
  
  Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Bradycardia Clinical Trial
	
Updated: 12/31/1969
  
  
  Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Bradycardia Clinical Trial
	
Updated: 12/31/1969
  
  
  Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Bradycardia Clinical Trial
	
Updated: 12/31/1969
  
  
  Micra Transcatheter Pacing System Post-Approval Registry
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Neurology Clinical Trial
	
Updated: 12/31/1969
  
  
  EDS in Ataxia Telangiectasia Patients
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Hematology Clinical Trial
	
Updated: 12/31/1969
  
  
  Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Hematology Clinical Trial
	
Updated: 12/31/1969
  
  
  Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Hematology Clinical Trial
	
Updated: 12/31/1969
  
  
  Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Hematology Clinical Trial
	
Updated: 12/31/1969
  
  
  Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Hematology Clinical Trial
	
Updated: 12/31/1969
  
  
  Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Hematology Clinical Trial
	
Updated: 12/31/1969
  
  
  Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Hematology Clinical Trial
	
Updated: 12/31/1969
  
  
  Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Hematology Clinical Trial
	
Updated: 12/31/1969
  
  
  Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Hematology Clinical Trial
	
Updated: 12/31/1969
  
  
  Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Hematology Clinical Trial
	
Updated: 12/31/1969
  
  
  Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Hematology Clinical Trial
	
Updated: 12/31/1969
  
  
  Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Hematology Clinical Trial
	
Updated: 12/31/1969
  
  
  Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  Strategic MAnagement to Optimize Response To Cardiac Resynchronization Therapy Registry
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  The Inotrope Evaluation and Research Patient Registry
		Status: Enrolling,
							Phase
													 			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Orthopedics / Podiatry Clinical Trial
	
Updated: 12/31/1969
  
  
  The PARTNER 3 - AVIV Trial
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases, Orthopedics / Podiatry Clinical Trial
	
Updated: 12/31/1969
  
  
  The PARTNER 3 - AVIV Trial
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Aortic Valve Stenosis Clinical Trial
	
Updated: 12/31/1969
  
  
  Prehabilitation for Patients Undergoing Transcatheter Aortic Valve Replacement
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Aortic Valve Stenosis Clinical Trial
	
Updated: 12/31/1969
  
  
  Prehabilitation for Patients Undergoing Transcatheter Aortic Valve Replacement
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Preserved Ejection Fraction (EMPEROR-Preserved)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  EMPagliflozin outcomE tRial in Patients With chrOnic heaRt Failure With Reduced Ejection Fraction (EMPEROR-Reduced)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Acute Myocardial Infarction Clinical Trial
	
Updated: 12/31/1969
  
  
  Prospective ARNI vs ACE Inhibitor Trial to DetermIne Superiority in Reducing Heart Failure Events After MI
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Acute Myocardial Infarction Clinical Trial
	
Updated: 12/31/1969
  
  
  Prospective ARNI vs ACE Inhibitor Trial to DetermIne Superiority in Reducing Heart Failure Events After MI
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  QP ExCELs: MultiPole Pacing (MPP) Sub-Study
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  QP ExCELs: MultiPole Pacing (MPP) Sub-Study
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  QP ExCELs: MultiPole Pacing (MPP) Sub-Study
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  QP ExCELs: MultiPole Pacing (MPP) Sub-Study
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  QP ExCELs: MultiPole Pacing (MPP) Sub-Study
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  QP ExCELs: MultiPole Pacing (MPP) Sub-Study
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  QP ExCELs: MultiPole Pacing (MPP) Sub-Study
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  QP ExCELs: MultiPole Pacing (MPP) Sub-Study
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Heart Failure Clinical Trial
	
Updated: 12/31/1969
  
  
  QP ExCELs: MultiPole Pacing (MPP) Sub-Study
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 12/31/1969
  
  
  Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 12/31/1969
  
  
  Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 12/31/1969
  
  
  Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Cardiology / Vascular Diseases Clinical Trial
	
Updated: 12/31/1969
  
  
  Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Heart Failure With Preserved Ejection Fraction
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Pulmonary Hypertension Associated With HFpEF Clinical Trial
	
Updated: 12/31/1969
  
  
  Study of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) Associated With Heart Failure With Preserved Ejection Fraction (HFpEF)
		Status: Enrolling,
							Phase
													 III			
				
		
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	 
  	
	Sudden Cardiac Death Clinical Trial
	
Updated: 12/31/1969
  
  
  Assessment of Primary Prevention Patients Receiving An ICD - Systematic Evaluation of ATP
		Status: Enrolling	
	Updated: 12/31/1969
Click here to add this to my saved trials
	    
	